These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33195128)

  • 1. The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies.
    Cascione M; De Matteis V; Leporatti S; Rinaldi R
    Front Bioeng Biotechnol; 2020; 8():566767. PubMed ID: 33195128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases.
    Khot KB; Gopan G; Bandiwadekar A; Jose J
    Ageing Res Rev; 2023 Jan; 83():101806. PubMed ID: 36427765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of nanocarrier-based CNS delivery systems.
    Tiwari SB; Amiji MM
    Curr Drug Deliv; 2006 Apr; 3(2):219-32. PubMed ID: 16611008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts.
    Fernandes F; Dias-Teixeira M; Delerue-Matos C; Grosso C
    Nanomaterials (Basel); 2021 Feb; 11(3):. PubMed ID: 33668341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS.
    Gondim BLC; da Silva Catarino J; de Sousa MAD; de Oliveira Silva M; Lemes MR; de Carvalho-Costa TM; de Lima Nascimento TR; Machado JR; Rodrigues V; Oliveira CJF; Cançado Castellano LR; da Silva MV
    Curr Pharm Des; 2019; 25(37):3983-3996. PubMed ID: 31612822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases.
    Duan L; Li X; Ji R; Hao Z; Kong M; Wen X; Guan F; Ma S
    Polymers (Basel); 2023 May; 15(9):. PubMed ID: 37177342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?
    Soares TB; Loureiro L; Carvalho A; Oliveira MECDR; Dias A; Sarmento B; Lúcio M
    Prog Neurobiol; 2018 Sep; 168():21-41. PubMed ID: 29641983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
    Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
    Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches.
    Agrahari V
    Neural Regen Res; 2017 Feb; 12(2):197-200. PubMed ID: 28400793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
    Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
    J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructure-based drug delivery systems for brain targeting.
    Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
    Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery to brain via the blood-brain barrier.
    Scherrmann JM
    Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.